USPTO serial 99388011
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Gangnam-gu, Seoul, KR
Gangnam-gu, Seoul, KR
Gangnam-gu, Seoul, KR
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Harris A. Wolin
Harris A. Wolin Myers Wolin, LLC100 South Jefferson Road, Suite 202Whippany, NJ 07981United States| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Skin care preparations for patch-shaped functional cosmetics including microneedles; Beauty microneedle patch; Patches containing sun screen and sun block for use on the skin; Cosmetic patches containing sunscreen and sun block for use on the skin; Gel eye patches for cosmetic purposes; Non-medicated skin care preparations in the form of dissolvable microneedle patches, namely, gels, serums, creams, toners, and skin-rejuvenating essences; Patches containing non-medicated cosmetic formulations delivered by dissolvable microneedles; Patches containing non-medicated UV-blocking agents; Gel eye patches containing non-medicated skin care preparations; Beauty microneedle patches containing non-medicated skin care preparations; Cosmetic microneedle patches containing sun protection preparations; Gel-based microneedle eye patches for cosmetic purposes | ACTIVE | — |
| 005 | Vitamin supplement patches; Adhesive skin patches for use in post-operative wound care; Skin patches for the transdermal delivery of pharmaceuticals; Drug delivery agents in the form of compounds, powders, and tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; Delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; Microneedle patch for medical purposes; Adhesive bandages for medical purposes; Adhesive skin patches for medical use; Transdermal patches for medical treatment of the skin; Transdermal microneedle patches for accelerating postoperative wound healing and scar reduction; Microneedle patches featuring salicylic acid and benzoyl peroxide for acne treatment; Microneedle patches featuring lidocaine for local pain relief; Microneedle patches featuring antihistamines for skin allergy management; Drug delivery agents in the form of dissolvable microneedle films and coatings that enhance penetration, sustained release of pharmaceutical preparations; Transdermal microneedle patches for delivering therapeutic active ingredients for addressing problems related to metabolic disorders, smoking cessation and neuromodulation, vaccination and immunotherapy, dermatology, pain and neurology, hormonal and systemic therapy, oncology, obesity and regenerative medicine and advanced biologics; Adhesive microneedle bandages containing analgesics or antimicrobial agents for wound healing and pain relief; Medical adhesive microneedle patches for delivering corticosteroids and antibiotics for dermatological conditions such as eczema and dermatitis; Transdermal microneedle patches for delivering prescription drugs for chronic pain, hormonal regulation, and metabolic disorder management | ACTIVE | — |
| 010 | Medical apparatus and instruments using microneedles for drug delivery; Cooling patches for medical purposes; Needles for medical purposes; Heating patches for medical treatment; Acupuncture needles; Medical apparatus and instruments incorporating microneedle arrays for drug delivery; Microneedle cooling patches for medical purposes; Microneedles and hypodermic needles for medical use; Chemically activated microneedle heating patches; Acupuncture microneedles | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 21, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 2, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 2, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 5, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 5, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 5, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 5, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 5, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 2, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 17, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 17, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 3, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 11, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 11, 2025 | NWAP | NEW APPLICATION ENTERED | — |